Clinical Trials on Platelet-Rich Plasma in Denmark

Total 145 results

Aarhus University Hospital
University of Aarhus

Completed

Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients

Extracorporeal Membrane Oxygenation | Platelet Aggregation | Platelet Activation | Intensive Care Units | Blood Platelets | Platelet Function Tests

Denmark
Terumo BCTbio

Terminated

Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study) (PRESS)

Thrombocytopenia

Denmark
Odense University Hospital

Completed

Near-infrared Spectroscopy Guided Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Myocardial Infarction | Myocardial Ischemia | Vascular Diseases | Coronary Artery Disease | Atherosclerosis | Lipid-Rich Atherosclerosis of Coronary Artery | Infarct Ischemia

Denmark
University of Copenhagen
Rigshospitalet, Denmark; Glostrup University Hospital, Copenhagen

Completed

Effects of Exercise Training on Cardiovascular Health in Middle-aged Women

Cardiovascular Diseases | Metabolic Diseases | Blood Platelet Disorders | Menopause | Cardiac Function Impaired

Denmark
Terumo BCT

Completed

Retrospective Data Collection of Routine Use With Spectra Optia® for Platelet Depletions (PLTD)

Thrombocytosis | Thrombocythemia | Myeloproliferative Disease

Denmark, Hungary
Medical University Innsbruck

Completed

Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion (FiT2012)

Blood Clotting | Blood Platelet Transfusion

Austria, Denmark
Aarhus University Hospital

Unknown

Coronary Artery Disease After Heart Transplantation (ECP)

Platelet Dysfunction | Coronary Artery Disease in Transplanted Heart (Diagnosis)

Denmark
Inge Marie Svane

Completed

CALR Exon 9 Mutant Peptide Vaccine to Patients With CALR-mutant Myeloproliferative Neoplasms

Essential Thrombocythemia | Myelofibrosis | Myeloproliferative Neoplasm, Unclassifiable

Denmark
Zealand University Hospital
Odense University Hospital; Rigshospitalet, Denmark

Withdrawn

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP)

Idiopathic Thrombocytopenic Purpura

Denmark
Inge Marie Svane

Completed

Dual Vaccine Trial in Myeloproliferative Neoplasms

Polycythemia Vera | Essential Thrombocythemia

Denmark
Thomas Lund

Completed

Bone Healing During Ninlaro Exposure (BONE)

Multiple Myeloma

Denmark
Lene Meldgaard Knudsen

Completed

Vaccination With PD-L1 Peptide Against Multiple Myeloma

Multiple Myeloma

Denmark
Vejle Hospital

Completed

"Monoclonal Antibodies for Treatment of Multiple Myeloma. Emphasis on the CD38 Antibody Daratumumab " (DARA)

Multiple Myeloma

Denmark
Henrik Gregersen

Unknown

Microdose Study of Melphalan, Bortezomib and Dexamethasone (Phase-0-MM)

Multiple Myeloma

Denmark
Thomas Lund

Recruiting

Home Treatment With Carfilzomib in Patients With Multiple Myeloma

Multiple Myeloma

Denmark
Thomas Lund

Completed

Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.

Multiple Myeloma

Denmark
Thomas Lund

Completed

Anti-neoplastic Treatment, Based on PRO Data Reported Through a MHealth App Solution in Multiple Myeloma

Multiple Myeloma

Denmark
Vejle Hospital
The University of Hong Kong

Completed

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma (ACVDL)

Multiple Myeloma

Denmark
Herlev Hospital

Completed

Diagnostic Imaging of Myeloma Bone Lesions (RAMP)

Multiple Myeloma

Denmark
Karin B. Ø. Dieperink

Completed

Perspectives of Subcutaneous Velcade at Home of Patients With Myeloma.

Multiple Myeloma

Denmark
Allarity Therapeutics
Medical Prognosis Institute A/S; Smerud Medical Research International AS

Terminated

Safety and Pharmacokinetics of Rising Doses of APO010 in Relapsed/Refractory Multiple Myeloma Patients Selected by DRP (SMR-3184)

Relapsed/Refractory Multiple Myeloma

Denmark
Herlev Hospital
Odense University Hospital

Completed

Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma

Relapsed Multiple Myeloma

Denmark
Charlotte Toftmann Hansen

Unknown

Clinical Evaluation of the Serum Free Light Chain Analysis

Multiple Myeloma

Denmark
Spine Centre of Southern Denmark

Recruiting

Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.

Multiple Myeloma | Vertebral Fracture

Denmark
University of Southern Denmark

Unknown

Myeloproliferative Neoplasms and Bone Structure

Primary Myelofibrosis | Polycythemia Vera | Thrombocythemia, Essential

Denmark
Zealand University Hospital
Odense University Hospital; Region of Southern Denmark; Association of Danish... and other collaborators

Completed

Exercise in Patients With Multiple Myeloma (EMMY)

Multiple Myeloma

Denmark
Lene Meldgaard Knudsen
IO Biotech

Terminated

PD-L1 Peptide Vaccination in High Risk Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

Denmark
Rigshospitalet, Denmark
Zealand University Hospital; Herlev Hospital; Fonden til Lægevidenskabens Fremme and other collaborators

Completed

The Molecular Characterization of Multiple Myeloma at Relapse (MM-FISH/DNA)

Multiple Myeloma

Denmark
Rigshospitalet, Denmark

Completed

Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease

Neoplasms | Lymphoma | Hematologic Diseases | Leukemia, Myeloid | Multiple Myeloma | Bone Marrow Transplantation

Denmark
Odense University Hospital

Unknown

Functional Imaging in Multiple Myeloma -PET/CT and Diffusion Weighted Imaging in Multiple Myeloma (FULIMA)

Multiple Myeloma

Denmark
Copenhagen University Hospital at Herlev

Completed

Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? (Bismuth-PBH)

Leukemia | Multiple Myeloma | Hematological Malignancies | Hematological Diseases | Blood Diseases | Malignant Lymphoma

Denmark
Thomas Lund

Completed

Prolonged Protection From Bone Disease in Multiple Myeloma (Magnolia)

Multiple Myeloma

Denmark
Vejle Hospital
Odense University Hospital

Completed

The Efficacy of Velcade on Bone Tissue During Myelomatosis (Bone Marrow Cancer)

Multiple Myeloma

Denmark
Cancer Trials Ireland
Sanofi; Dana-Farber Cancer Institute

Recruiting

Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma (Isa-RVD)

Multiple Myeloma

Denmark, Ireland
Oslo University Hospital
Helse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study Group

Active, not recruiting

REST - Replacing Steroids in the Transplant Ineligble (REST)

Multiple Myeloma

Norway, Denmark
Vejle Hospital
Odense University Hospital; Novartis

Completed

Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer

Breast Cancer | Multiple Myeloma

Denmark
Thomas Stauffer Larsen

Completed

A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms (DALIAH)

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia

Denmark
Oslo University Hospital
Nordic Myeloma Study Group

Active, not recruiting

Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. (CONPET)

Myeloma

Norway, Denmark, Sweden
Henrik Gregersen
Danish Myeloma Study Group

Terminated

Clarithromycin in Multiple Myeloma Induction Therapy (CLAIM)

Multiple Myeloma

Denmark
Nordic Myeloma Study Group

Unknown

Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients

Multiple Myeloma

Denmark
Copenhagen University Hospital at Herlev

Completed

The Efficacy of Dexamethasone Versus Dexamethasone Combined With Rituximab in Patients With Newly Diagnosed Idiopathic Thrombocytopenic Purpura (ITP)

Idiopathic Thrombocytopenic Purpura

Denmark
Sirtris, a GSK Company
GlaxoSmithKline

Terminated

A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma

Multiple Myeloma

United Kingdom, Denmark
Henrik Gregersen
Danish Myeloma Study Group

Unknown

Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma (SUTRICA)

Multiple Myeloma | Infection

Denmark
Henrik Gregersen
Nordic Myeloma Study Group

Unknown

Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell Support (CARFI)

Multiple Myeloma

Finland, Denmark, Sweden, Norway, Lithuania
Janssen Research & Development, LLC

Completed

Daratumumab (HuMax®-CD38) Safety Study in Multiple Myeloma

Multiple Myeloma

United States, Netherlands, Sweden, Denmark
Ida Bruun Kristensen
Odense Patient Data Explorative Network; Karyopharm Therapeutics Inc

Active, not recruiting

Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients (SABLe)

Multiple Myeloma

Denmark, Norway, Estonia
Copenhagen University Hospital at Herlev

Unknown

A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia

Polycythemia Vera | Essential Thrombocythemia

Sweden, United Kingdom, Denmark, Netherlands
Odense University Hospital
Danish Myeloma Study Group

Active, not recruiting

Quality of Life the Danish Multiple Myeloma Patients (QoL-MM)

Quality of Life | Multiple Myeloma

Denmark
Nordic Myeloma Study Group
Janssen-Cilag Ltd.

Unknown

Bortezomib and High-dose Melphalan at Myeloma Relapse

Multiple Myeloma

Denmark, Norway, Sweden
GlycoMimetics Incorporated

Completed

A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma

Multiple Myeloma

Ireland, Denmark, United Kingdom, Germany

Clinical Trials on Platelet-Rich Plasma in Denmark

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations